Skip to content
Screener

Enovis ENOV Operating Cash Flow

Operating Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$8.62B+122%
Stryker logo
StrykerSYK
$1.26B+13.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$6.22M-153%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$447.8M+18.4%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$7.24M+72.5%
ESAB logo
ESABESAB
$33.42M-28.3%

Other financials

Income statement

See full
Revenue$582.8M+3.2%
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.52B+3.1%
Enterprise value$2.81B-0.4%
P/S0.7×0.0×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemSix Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Inventories, net(21,742)(57,282)
Accounts payable4,98023,161
Other operating assets and liabilities4,32132,145
Net cash provided by operating activities98,98346,173
Cash flows from investing activities:
Purchases of property, plant and equipment and intangibles(96,699)(87,631)
Payments for acquisitions, net of cash received, and investments(1,407)(24,290)
Cash received upon settlement of derivatives1,601

Item 1. Financial Statements

FAQ

What is Enovis's operating cash flow?
Enovis (ENOV) reported operating cash flow of $75.03M in Q2 2026.
How has Enovis's operating cash flow changed year-over-year?
Enovis's operating cash flow increased by 57.1% year-over-year, from $47.77M to $75.03M.
What is the long-term trend for Enovis's operating cash flow?
Over 3 years (2021 to 2025), Enovis's operating cash flow has grown at a -15.2% compound annual growth rate (CAGR), from $356.1M to $217.29M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Enovis's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude